Cellavita Pesquisa Científica Ltda Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2017
NCT02728115
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Cellavita Pesquisa Científica Ltda

Active Ingredients

Drugs in Phase 3 Trials (2)

cellavita (3 trials)

nestacell (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Huntington Disease (Phase 3)

Pneumonia (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 2